The FDA approved a supplemental new drug application for Ryzumvi, a preservative-free eye drop, for the treatment of presbyopia.
“Presbyopia affects approximately 90% of Americans over age 45, making everyday activities like reading, using smartphones and working on computers increasingly difficult. Many patients rely on reading glasses or other corrective lenses, creating a significant need for convenient, noninvasive treatment options,” George Magrath, MD, MBA, MS, CEO of Opus Genetics, told Healio. “Phentolamine ophthalmic solution 0.75% offers a pharmacological alternative designed to